Ibuprofen: a weak inhibitor of carbonic anhydrase II.


Journal

Acta crystallographica. Section F, Structural biology communications
ISSN: 2053-230X
Titre abrégé: Acta Crystallogr F Struct Biol Commun
Pays: United States
ID NLM: 101620319

Informations de publication

Date de publication:
01 Nov 2022
Historique:
received: 05 08 2022
accepted: 05 10 2022
entrez: 2 11 2022
pubmed: 3 11 2022
medline: 5 11 2022
Statut: ppublish

Résumé

Carbonic anhydrases (CAs) are drug targets for a variety of diseases. While many clinically relevant CA inhibitors are sulfonamide-based, novel CA inhibitors are being developed that incorporate alternative zinc-binding groups, such as carboxylic acid moieties, to develop CA isoform-specific inhibitors. Here, the X-ray crystal structure of human CA II (hCA II) in complex with the carboxylic acid ibuprofen [2-(4-isobutylphenyl)propanoic acid, a common over-the-counter nonsteroidal anti-inflammatory drug] is reported to 1.54 Å resolution. The binding of ibuprofen is overlaid with the structures of other carboxylic acids in complex with hCA II to compare their inhibition mechanisms by direct or indirect (via a water) binding to the active-site zinc. Additionally, enzyme-inhibition assays using ibuprofen, nicotinic acid and ferulic acid were performed with hCA II to determine their IC

Identifiants

pubmed: 36322425
pii: S2053230X22009761
doi: 10.1107/S2053230X22009761
pmc: PMC9629514
doi:

Substances chimiques

Carbonic Anhydrase II EC 4.2.1.-
Carbonic Anhydrase Inhibitors 0
Ibuprofen WK2XYI10QM
Carboxylic Acids 0
Zinc J41CSQ7QDS
Carbonic Anhydrase IX EC 4.2.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

395-402

Références

Agents Actions. 1989 Jun;27(3-4):455-7
pubmed: 2801337
Acta Crystallogr F Struct Biol Commun. 2019 Mar 1;75(Pt 3):166-170
pubmed: 30839290
J Enzyme Inhib Med Chem. 2022 Dec;37(1):930-939
pubmed: 35306936
Nat Rev Drug Discov. 2008 Feb;7(2):168-81
pubmed: 18167490
J Med Chem. 2016 Mar 10;59(5):2192-204
pubmed: 26882437
J Chem Inf Model. 2011 Oct 24;51(10):2778-86
pubmed: 21919503
J Med Chem. 2021 Feb 11;64(3):1713-1724
pubmed: 33523653
Bioorg Med Chem. 2013 Nov 15;21(22):7210-5
pubmed: 24090602
J Enzyme Inhib Med Chem. 2016;31(3):345-60
pubmed: 26619898
Nat Struct Biol. 2003 Dec;10(12):980
pubmed: 14634627
Biochem J. 1940 Sep;34(8-9):1163-76
pubmed: 16747299
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Eur J Biochem. 1975 Nov 1;59(1):253-9
pubmed: 1249
Int J Mol Sci. 2016 Jul 16;17(7):
pubmed: 27438828
ACS Med Chem Lett. 2017 Jul 31;8(9):941-946
pubmed: 28947941
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 May 1;65(Pt 5):495-8
pubmed: 19407386
Biochemistry. 2010 Jan 19;49(2):249-51
pubmed: 20000378
J Med Chem. 2020 Jan 9;63(1):321-333
pubmed: 31794211
Chemistry. 2016 Jan 4;22(1):97-100
pubmed: 26507456
J Med Chem. 2022 Jan 13;65(1):824-837
pubmed: 34958217
Can Med Assoc J. 1974 Jun 22;110(12):1370-2
pubmed: 4599671
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Biochem Biophys Res Commun. 1964;14:256-61
pubmed: 4953741
Br J Pharmacol. 2008 Mar;153 Suppl 1:S68-75
pubmed: 18037924
ChemMedChem. 2022 Jun 3;17(11):e202200148
pubmed: 35388618
Gene. 1992 Aug 1;117(1):113-7
pubmed: 1644301
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Acta Crystallogr D Biol Crystallogr. 2014 Jun;70(Pt 6):1758-63
pubmed: 24914985
Methods Enzymol. 2020;634:281-309
pubmed: 32093837
Chem Commun (Camb). 2012 May 28;48(43):5259-61
pubmed: 22531842
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Med Res Rev. 2003 Mar;23(2):146-89
pubmed: 12500287
J Enzyme Inhib Med Chem. 2015 Dec;30(6):955-60
pubmed: 25775095
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14
pubmed: 23793146
Biochemistry. 2010 Jan 26;49(3):415-21
pubmed: 20025241
J Oral Surg. 1977 Nov;35(11):898-903
pubmed: 269932
Skin Pharmacol Physiol. 2018;31(6):332-336
pubmed: 30235459
Physiol Rev. 1967 Oct;47(4):595-781
pubmed: 4964060
Bioorg Med Chem. 2014 Jan 1;22(1):334-40
pubmed: 24300919
Biomolecules. 2020 Mar 31;10(4):
pubmed: 32244293

Auteurs

Jacob Combs (J)

Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.

Jacob Andring (J)

Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.

Robert McKenna (R)

Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH